New antimalarial treatment for KwaZulu-Natal.
Baker
L
L
Barnes
K
K
D000367:Age Factors; D000962:Antimalarials / Q000627:therapeutic use*; D000077611:Artemether, Lumefantrine Drug Combination; D037621:Artemisinins; D001835:Body Weight; D002648:Child; D002675:Child, Preschool; D004334:Drug Administration Schedule; D004338:Drug Combinations; D004351:Drug Resistance; D004983:Ethanolamines; D005449:Fluorenes / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000453:epidemiology / Q000469:parasitology; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D012717:Sesquiterpenes / Q000627:therapeutic use*; D013019:South Africa / Q000453:epidemiology
D000962:Antimalarials; D000077611:Artemether, Lumefantrine Drug Combination; D037621:Artemisinins; D004338:Drug Combinations; D004983:Ethanolamines; D005449:Fluorenes; D012717:Sesquiterpenes